Laminate Medical Technologies

About

Headcount over time

Offices

Q&A

What is Laminate Medical Technologies' primary product?

Laminate Medical Technologies' flagship product is VasQ™, an external support device designed to improve vascular access for hemodialysis patients by addressing primary fistula failure and reducing the need for repeat procedures.

When was Laminate Medical Technologies founded?

Laminate Medical Technologies was founded in 2012.

What is the current employee count for Laminate Medical Technologies?

Laminate Medical Technologies has 21 employees, falling within the 11-50 employee bucket.

What was the most recent funding round for Laminate Medical Technologies?

Laminate Medical Technologies completed an E Round of funding in April 2024, with Tal Ventures as a lead investor.

What was the total amount raised by Laminate Medical Technologies?

Laminate Medical Technologies has raised a total of $24,054,000 USD.

Has Laminate Medical Technologies received FDA approval for its VasQ device?

Yes, the VasQ™ device has received FDA De Novo approval and CE approval in Europe. In September 2023, Laminate Medical also announced FDA clearance for the VasQ AVF creation device.

When was the first U.S. implantation of VasQ after FDA De Novo approval?

The first U.S. implantation of VasQ™ since FDA De Novo was granted occurred in January 2024.

What was a significant development regarding VasQ™ Extravascular Support in September 2024?

In September 2024, VasQ™ Extravascular Support was granted Transitional Pass-Through (TPT) Payment.

Team · 11

Tammy Gilon

Founder · CEO & Co-founder

Dr. Eyal Orion

Founder · Co-founder & Board Member

Anthony Rodriguez

VP Market Access

Galit Itzhaki

VP Clinical Development

Ran Agam

VP Operations & Engineering

Orit Yarden

VP Clinical & Regulatory Affairs

Kent Butler

Head of US Sales

Gil Koubi

Head of Global-OUS Sales

Ido Nisenboim

Consulting CFO

Dana Eshed

Legal Counsel

Jose Calle Gordo

Board Member

Sectors & technology

Highlights

Tags